Page last updated: 2024-10-26

3,3'-diindolylmethane and Carcinoma, Non-Small Cell Lung

3,3'-diindolylmethane has been researched along with Carcinoma, Non-Small Cell Lung in 3 studies

3,3'-diindolylmethane: anti-inflammatory from edible cruciferous vegetables; a cytochrome P-450 antagonist

Research Excerpts

ExcerptRelevanceReference
" Here we found that the phytochemical 3,3'-Diindolylmethane (DIM) can inhibit the growth and also the invasion of breast cancer, glioma, and non-small cell lung cancer cells regardless of which EGFR mutant is expressed and the drug-resistant phenotype."3.763,3'-Diindolylmethane (DIM) inhibits the growth and invasion of drug-resistant human cancer cells expressing EGFR mutants. ( Huang, KL; Rahimi, M; Tang, CK, 2010)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ichite, N2
Chougule, MB1
Jackson, T2
Fulzele, SV1
Safe, S2
Singh, M2
Rahimi, M1
Huang, KL1
Tang, CK1
Chougule, M1
Patel, AR1

Other Studies

3 other studies available for 3,3'-diindolylmethane and Carcinoma, Non-Small Cell Lung

ArticleYear
Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Jan-15, Volume: 15, Issue:2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Caspase 3; Cell Line, Tum

2009
3,3'-Diindolylmethane (DIM) inhibits the growth and invasion of drug-resistant human cancer cells expressing EGFR mutants.
    Cancer letters, 2010, Sep-01, Volume: 295, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell

2010
Inhalation delivery of a novel diindolylmethane derivative for the treatment of lung cancer.
    Molecular cancer therapeutics, 2010, Volume: 9, Issue:11

    Topics: Administration, Inhalation; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Lin

2010